FDA NDC Directory · JSON-LD · Markdown

Oxaliplatin

NDC 55150-331 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerEugia US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA205529
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (5 mg/mL)
Marketing started20170921
Package count1

External sources

Source: openFDA. Public-domain (CC0).